SarcopeniaNCT07421648
BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4
A study testing BandPass System in people with Sarcopenia and Frailty, run by SynchroHealth LLC at 2 sites in United States.
Trial summary
This study evaluates a home-based strengthening program supported by the BandPass system, which includes a Bluetooth-enabled resistance exercise band, a mobile app that provides real-time feedback, and a clinician dashboard for remote monitoring. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Sarcopenia, Frailty
- What is being tested?
- BandPass System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 39 participants
- Where
- 2 sitesUnited States
- Study dates
- Feb 2026to Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- English speaking
- Age 65 or older
- Willing to use the BandPass device
- Access to high-speed internet Wi-Fi at home
- Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) Survey score of =4 or Frail Scale Survey score of 3-5
Who cannot join
- A medical record diagnosis of dementia -research activities require the ability to engage in the intervention, complete questionnaires and interact with others, all of which may be challenging in individuals with cognitive impairment
- Cognitive impairment measured by the 6-item Callahan screener
- Psychiatric diagnosis that would interfere with study participation and require significant modification to meet their needs such as major depressive disorder, substance abuse, suicidal ideation or severe mental illness (schizophrenia, bipolar disorder)
- A medical record diagnosis of a vestibular disorder
- A medical record diagnosis of fall risk
- Life-threatening illness including those receiving palliative care or hospice services
- Nursing facility or hospital admission in the past three months that is deemed to be contraindicated by the PI to participate
- Individuals unwilling/unable to provide consent
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States2 sites
UNC Chapel Hill School of Medicine
Chapel Hill, North Carolina, 27514
UNC Eastowne Medical Office Building
Chapel Hill, North Carolina, 27514
About this study
This study evaluates a home-based strengthening program supported by the BandPass system, which includes a Bluetooth-enabled resistance exercise band, a mobile app that provides real-time feedback, and a clinician dashboard for remote monitoring. The goal of this clinical trial is to determine whether older adults living independently can feasibly use the BandPass system and whether participation in a BandPass-guided strengthening program improves functional performance.
The main questions this study seeks to answer are:
Read more
Whether older adults can independently and consistently use the BandPass system as part of a structured home-based strengthening program (feasibility and acceptability).
Whether the BandPass-guided program improves functional outcomes, including lower-extremity strength, mobility, and gait performance.
Participants will complete a 12-week home strengthening program using the BandPass system, attend in-person and virtual assessment visits to measure strength and mobility, and complete questionnaires related to usability, safety, and overall experience. If successful, this study will provide preliminary evidence supporting the use of remote monitoring technologies to promote strength, mobility, and independence in aging adults and inform the design of future larger-scale trials.
Read the detailed description
Purpose: Consistent with the research priorities of the National Institute on Aging to support mobility, strength, and functional independence in older adults, this protocol will evaluate the feasibility, acceptability, and preliminary efficacy of the BandPass system, a remote monitoring platform consisting of a Bluetooth-enabled resistance exercise band, a mobile application providing real-time feedback, and a clinician dashboard for remote oversight. This Phase II Aim 4 trial examines whether a home-based strengthening intervention supported by BandPass can be feasibly implemented in older adults at risk for sarcopenia or functional decline, and whether participation leads to improvements in physical function, including lower-extremity strength, gait speed, and mobility.
Procedures (Methods): This is an 8-week, single-arm, pre/post intervention trial enrolling 39 older adults aged 65 years and older who are at risk for sarcopenia, frailty, or functional decline. Participants will complete a structured home-based strengthening program using the BandPass system three times per week. Baseline in-person assessments will include strength testing, gait assessment, mobility measures, body composition, and device training. At Week 4, participants will complete a virtual visit for interim assessment of functional status. At Week 8, they will return for repeat functional testing and usability surveys. Throughout the intervention, participants will use the BandPass resistance band and mobile app for all strengthening sessions, with real-time feedback on effort, tempo, and repetitions. Exercise data will be automatically transmitted to the clinician dashboard, allowing the study team to monitor adherence, performance, and safety. Participants will complete weekly surveys regarding usability, comfort, and perceived exertion, and may contact study staff with questions or concerns at any point. Safety monitoring, adverse event tracking, and protocol fidelity procedures will be conducted throughout the study.
Aim 1: Evaluate the feasibility and acceptability of deploying the BandPass system in older adults at risk for sarcopenia or frailty. We hypothesize that BandPass will be feasible and acceptable, with at least 80% of participants reporting satisfaction with the system and at least 75% of prescribed sessions completed.
Aim 2: Examine the preliminary efficacy of the 8-week BandPass-guided strengthening program on physical function. Improvements are expected in measures including grip strength, Short Physical Performance Battery scores, gait speed, and chair stand performance from baseline to Week 8.
Aim 3: Characterize patterns of engagement with the BandPass system, including exercise frequency, duration, force output, tempo, and repetition quality. These metrics will be used to inform optimization of future technology-supported strengthening interventions and to guide development of larger-scale trials.
- Conditions
- Sarcopenia, Frailty
- Being tested
- BandPass System
- Keywords
- Bandpass, Older Adults, Physical Function, Mobility
- Medical subject headings
- Sarcopenia, Frailty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BandPass SystemDevice
The BandPass system consists of a Bluetooth-enabled resistance exercise band paired with a mobile application that provides real-time feedback on exercise performance and transmits data to a clinician dashboard for remote monitoring. Participants will use the BandPass system for all strengthening sessions during the 8-week intervention.
| Study group | Role | What they receive |
|---|---|---|
| Bandpass Strengthening Program | Experimental | Participants will complete an 8-week home-based strengthening program using the BandPass system. All participants will perform strengthening exercises three times per week and complete in-person and virtual functional assessments. Receives: Device: BandPass System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise Session Adherence to the Bandpass System
Exercise session adherence will be assessed as the percentage of prescribed BandPass-supported strengthening sessions completed by participants over the 8-week intervention period. Participants are prescribed three strengthening sessions per week. Adherence will be calculated as: (number of completed sessions ÷ number of prescribed sessions) × 100. Adherence will be summarized at Weeks 4 and 8 to evaluate feasibility and continued use of the BandPass system among older adults.
Measured: 0, 4, 8 weeks
Secondary outcomes (19)
Change in Gait Speed from Baseline
Gait speed will be assessed using the 4-meter walk test. Participants will be instructed to walk at their usual pace over a 4-meter course, and the time to complete the course will be recorded in seconds. Gait speed will be calculated as distance (4 meters) divided by time (seconds), reported in meters/second (m/s). The outcome will be expressed as change in gait speed from baseline to Week 4 and from baseline to Week 8, with positive values indicating faster walking speed.
Measured: 0, 4, 8 weeks
Change in 30-Second Sit-to-Stand Performance from Baseline
This is a construct of physical function that predicts falls and disability and is sensitive to change. The 30-second sit-to-stand test is administered using a folding chair without arms and involves recording the number of stands from a seated position a person can complete in 30 seconds. Change in 30-second sit-to-stand repetitions will be reported from baseline to Week 4 and from baseline to Week 8. An improvement in repetitions will represent an improvement in physical function. The continuous value correlates with quadriceps Minimal Clinically Important Difference (2.0 repetitions).
Measured: 0, 4, 8 weeks
Change in Grip Strength from Baseline
An objective measure related to upper extremity strength that predicts mobility disability. Using a Jamar dynamometer, change in participants' maximal grip strength will be measured in kilograms. Absolute change in grip strength will be reported from baseline to Week 4 and from baseline to Week 8. An increase in kilograms will represent an improvement in physical function. No cutoffs will be used, and analyses will use the continuous value.
Measured: 0, 4, 8 weeks
Change in Patient reported outcomes measurement information systems (PROMIS) - Global health
PROMIS (Patient-Reported Outcomes Measurement Information System) Global Health gauges physical, mental, and social aspects of health using a standardized 5-point scale. Scores are standardized to the general population (mean = 50, SD = 10; range 0-100), with higher scores indicating better health. Change in PROMIS Global Health scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in Patient reported outcomes measurement information systems - Physical function
PROMIS Physical Function is a self-reported measure of mobility and activities of daily living using a standardized 5-point scale. Scores are standardized to the general population (mean = 50, SD = 10; range 0-100), with higher scores indicating better physical function. Change in PROMIS Physical Function scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in Pittsburgh Fatigability questionnaire
The 15-item Pittsburgh Fatigability Scale measures perceived fatigue related to sedentary, social, lifestyle, and physical activities across a range of intensities (0-50 scale). Higher scores indicate greater perceived physical or mental fatigability, and scores ≥15 (physical) or ≥13 (mental) indicate higher fatigability that may lead to reduced performance or restricted activity. Change in Pittsburgh Fatigability scores will be assessed from baseline to Week 4 and from baseline to Week 8. A reduction in score will represent an improvement in fatigability.
Measured: 0, 4, 8 weeks
Change in Exercise Self-Efficacy
The Self-Efficacy for Exercise Scale (range 0-90) is based on Social Cognitive Theory, with higher scores indicating greater confidence in initiating and maintaining exercise behaviors. Change in exercise self-efficacy scores will be assessed from baseline to Week 4 and from baseline to Week 8. Positive changes will reflect improved self-efficacy, while negative changes will reflect reduced self-efficacy.
Measured: 0, 4, 8 weeks
Change in Technology Self-Efficacy
A 10-item Likert scale (1-10) will be used to assess daily technology self-efficacy, with higher scores indicating greater self-efficacy (range 0-100). Change in Technology Self-Efficacy scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in Treatment Self-Regulation: Exercise
A validated 15-item, 7-point scale (range 0-100) reflecting autonomous and controlled motivation for exercise. Change in Treatment Self-Regulation scores will be assessed from baseline to Week 4 and from baseline to Week 8, with higher scores indicating better outcomes.
Measured: 0, 4, 8 weeks
Change in Patient activation measure
The Patient Activation Measure assesses knowledge, skills, and confidence for managing one's health, providing insight into motivation, behaviors, attitudes, and outcomes (score range 0-100, with higher scores indicating greater activation). Change in Patient Activation Measure scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in Older Americans Resources and Services (OARS) Functional Assessment Score
The Older Americans Resources and Services (OARS) Functional Assessment is a self-reported measure of functional ability in activities of daily living (ADLs) and instrumental activities of daily living (IADLs). Scores are calculated according to standard OARS scoring procedures, with higher scores indicating greater functional independence (score ≥12 indicating no impairment). Change in OARS Functional Assessment scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in Outcome Expectancies for Exercise and Technology Use
Outcome expectancies for exercise and technology use will be assessed using a self-reported questionnaire evaluating participants' beliefs about their ability to prevent or improve loss of strength, muscle mass, and overall health through physical activity and use of technology. Participants respond using a 4-point Likert scale ranging from strongly agree to strongly disagree, with higher agreement indicating more positive outcome expectancies. Change in outcome expectancy scores will be assessed from baseline to Week 4 and from baseline to Week 8.
Measured: 0, 4, 8 weeks
Change in System Usability Scale (SUS) Score
System usability will be assessed using the System Usability Scale (SUS), a validated self-reported questionnaire that measures perceived usability of a system. The SUS consists of 10 items, each rated on a 5-point Likert scale ranging from strongly disagree to strongly agree. Item responses are scored and summed according to standard SUS scoring procedures to generate a total score ranging from 0 to 100, with higher scores indicating better perceived system usability. The outcome will be expressed as the change in SUS total score from 4 weeks to 8 weeks.
Measured: 4, 8 weeks
Change in Learnability Score of the BandPass System
Learnability of the BandPass system will be assessed using a self-reported questionnaire evaluating ease of use, confidence, navigation, and ability to use the system seamlessly over time. Participants rate items related to the BandPass resistance exercise band, the BandPass app, and the combined system using 10-point Likert-type scales. Higher scores indicate greater perceived ease of learning and confidence in using the system. Change in learnability scores from 4 weeks to 8 weeks will be reported.
Measured: 4, 8 weeks
Change in Efficiency and Technology Acceptance Questionnaire Scores
Technology acceptance and efficiency will be measured using a self-reported questionnaire evaluating confidence in independent device use, perceived usefulness, convenience, burden, satisfaction, and efficiency. Scores are generated using 10-point Likert-type scales and summarized according to standard scoring procedures, with higher scores indicating more positive perceptions of technology acceptance and efficiency. Change in efficiency and technology acceptance scores will be assessed from Week 4 to Week 8.
Measured: 4, 8 weeks
Change in User Experience Questionnaire (UEQ) Scores
User experience of the BandPass system will be assessed using the User Experience Questionnaire (UEQ), a validated self-reported questionnaire that evaluates participants' perceptions of the system across multiple dimensions, including attractiveness, clarity, efficiency, dependability, stimulation, and novelty. The UEQ consists of paired contrasting attributes rated on a 7-point semantic differential scale ranging from 1 to 7, with higher scores indicating a more positive user experience. Scores will be calculated according to standard UEQ scoring procedures. Change in UEQ scores from 4 weeks to 8 weeks will be reported.
Measured: 4, 8 weeks
Telehealth Usability Survey
A single-item Likert scale (1-10) will be used to assess perceived usefulness, ease of use, effectiveness, reliability, and satisfaction with the BandPass system (range 0-100), with higher scores indicating better outcomes. Scores will be assessed at Week 4 and Week 8, and change in Telehealth Usability Survey scores between these timepoints will be reported.
Measured: 4, 8 weeks
Change in Usefulness, Ease of Use, Ease of Learning, and Satisfaction Questionnaire Scores
Perceived usefulness, ease of use, ease of learning, and satisfaction with the BandPass system will be assessed using a self-reported questionnaire. The questionnaire includes items evaluating effectiveness, productivity, usefulness, efficiency, ease of use, flexibility, learnability, error recovery, and overall satisfaction with the system. Items are rated on a Likert-type scale ranging from strongly disagree to strongly agree. Higher scores indicate more positive perceptions of the system. Change in questionnaire scores from 4 weeks to 8 weeks will be reported.
Measured: 4, 8 weeks
Willingness to Pay for the BandPass System
Willingness to pay for the BandPass system will be assessed using a self-reported questionnaire evaluating participants' willingness to pay for the application and exercise device and their willingness to travel to an exercise center in lieu of using the system in a home setting. Participants select predefined cost ranges and travel time categories reflecting perceived value and acceptability of the system.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study startFeb 2026 (estimated)
- Primary completionJun 2026 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SarcopeniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 39 participants (estimated)
Sponsor and investigators
- Lead sponsor
- SynchroHealth LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- University of North Carolina, Chapel Hill
- Responsible party
- Sponsor
- Investigators
- Eric Ryan, PhD, Principal investigator, University of North Carolina, Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07421648
- Sponsor's protocol ID
- 24-2804
- Status last verified
- Feb 2026
- First submitted
- 12 Feb 2026
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Study data is proprietary.
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4
- ClinicalTrials.gov ID
- NCT07421648
- Acronym / sponsor ID
- 24-2804
- Conditions
- Sarcopenia, Frailty
- Keywords
- Bandpass, Older Adults, Physical Function, Mobility
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 39 participants (estimated)
- Lead sponsor
- SynchroHealth LLCIndustry (pharma, biotech, devices)
- Collaborators
- University of North Carolina, Chapel Hill
- Study start
- Feb 2026 (estimated)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates a home-based strengthening program supported by the BandPass system, which includes a Bluetooth-enabled resistance exercise band, a mobile app that provides real-time feedback, and a clinician dashboard for remote monitoring. The goal of this clinical trial is to determine whether older adults living independently can feasibly use the BandPass system and whether participation in a BandPass-guided strengthening program improves functional performance.
The main questions this study seeks to answer are:
Whether older adults can independently and consistently use the BandPass system as part of a structured home-based strengthening program (feasibility and acceptability).
Whether the BandPass-guided program improves functional outcomes, including lower-extremity strength, mobility, and gait performance.
Participants will complete a 12-week home strengthening program using the BandPass system, attend in-person and virtual assessment visits to measure strength and mobility, and complete questionnaires related to usability, safety, and overall experience. If successful, this study will provide preliminary evidence supporting the use of remote monitoring technologies to promote strength, mobility, and independence in aging adults and inform the design of future larger-scale trials.
Detailed description
Purpose: Consistent with the research priorities of the National Institute on Aging to support mobility, strength, and functional independence in older adults, this protocol will evaluate the feasibility, acceptability, and preliminary efficacy of the BandPass system, a remote monitoring platform consisting of a Bluetooth-enabled resistance exercise band, a mobile application providing real-time feedback, and a clinician dashboard for remote oversight. This Phase II Aim 4 trial examines whether a home-based strengthening intervention supported by BandPass can be feasibly implemented in older adults at risk for sarcopenia or functional decline, and whether participation leads to improvements in physical function, including lower-extremity strength, gait speed, and mobility.
Procedures (Methods): This is an 8-week, single-arm, pre/post intervention trial enrolling 39 older adults aged 65 years and older who are at risk for sarcopenia, frailty, or functional decline. Participants will complete a structured home-based strengthening program using the BandPass system three times per week. Baseline in-person assessments will include strength testing, gait assessment, mobility measures, body composition, and device training. At Week 4, participants will complete a virtual visit for interim assessment of functional status. At Week 8, they will return for repeat functional testing and usability surveys. Throughout the intervention, participants will use the BandPass resistance band and mobile app for all strengthening sessions, with real-time feedback on effort, tempo, and repetitions. Exercise data will be automatically transmitted to the clinician dashboard, allowing the study team to monitor adherence, performance, and safety. Participants will complete weekly surveys regarding usability, comfort, and perceived exertion, and may contact study staff with questions or concerns at any point. Safety monitoring, adverse event tracking, and protocol fidelity procedures will be conducted throughout the study.
Aim 1: Evaluate the feasibility and acceptability of deploying the BandPass system in older adults at risk for sarcopenia or frailty. We hypothesize that BandPass will be feasible and acceptable, with at least 80% of participants reporting satisfaction with the system and at least 75% of prescribed sessions completed.
Aim 2: Examine the preliminary efficacy of the 8-week BandPass-guided strengthening program on physical function. Improvements are expected in measures including grip strength, Short Physical Performance Battery scores, gait speed, and chair stand performance from baseline to Week 8.
Aim 3: Characterize patterns of engagement with the BandPass system, including exercise frequency, duration, force output, tempo, and repetition quality. These metrics will be used to inform optimization of future technology-supported strengthening interventions and to guide development of larger-scale trials.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Bandpass Strengthening Program | Experimental | Device: BandPass SystemParticipants will complete an 8-week home-based strengthening program using the BandPass system. All participants will perform strengthening exercises three times per week and complete in-person and virtual functional assessments. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- English speaking
- Age 65 or older
- Willing to use the BandPass device
- Access to high-speed internet Wi-Fi at home
- Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) Survey score of =4 or Frail Scale Survey score of 3-5
Key exclusion criteria (8 listed)
- A medical record diagnosis of dementia -research activities require the ability to engage in the intervention, complete questionnaires and interact with others, all of which may be challenging in individuals with cognitive impairment
- Cognitive impairment measured by the 6-item Callahan screener
- Psychiatric diagnosis that would interfere with study participation and require significant modification to meet their needs such as major depressive disorder, substance abuse, suicidal ideation or severe mental illness (schizophrenia, bipolar disorder)
- A medical record diagnosis of a vestibular disorder
- A medical record diagnosis of fall risk
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BandPass SystemThe BandPass system consists of a Bluetooth-enabled resistance exercise band paired with a mobile application that provides real-time feedback on exercise performance and transmits data to a clinician dashboard for remote monitoring. Participants will use the BandPass system for all strengthening sessions during the 8-week intervention. | Device | Bandpass Strengthening Program |
Primary outcome
Exercise Session Adherence to the Bandpass System
Time frame: 0, 4, 8 weeks
Exercise session adherence will be assessed as the percentage of prescribed BandPass-supported strengthening sessions completed by participants over the 8-week intervention period. Participants are prescribed three strengthening sessions per week. Adherence will be calculated as: (number of completed sessions ÷ number of prescribed sessions) × 100. Adherence will be summarized at Weeks 4 and 8 to evaluate feasibility and continued use of the BandPass system among older adults.
19 secondary outcomes
Change in Gait Speed from Baseline
Time frame: 0, 4, 8 weeks
Change in 30-Second Sit-to-Stand Performance from Baseline
Time frame: 0, 4, 8 weeks
Change in Grip Strength from Baseline
Time frame: 0, 4, 8 weeks
Change in Patient reported outcomes measurement information systems (PROMIS) - Global health
Time frame: 0, 4, 8 weeks
Change in Patient reported outcomes measurement information systems - Physical function
Time frame: 0, 4, 8 weeks
Change in Pittsburgh Fatigability questionnaire
Time frame: 0, 4, 8 weeks
Change in Exercise Self-Efficacy
Time frame: 0, 4, 8 weeks
Change in Technology Self-Efficacy
Time frame: 0, 4, 8 weeks
Change in Treatment Self-Regulation: Exercise
Time frame: 0, 4, 8 weeks
Change in Patient activation measure
Time frame: 0, 4, 8 weeks
Change in Older Americans Resources and Services (OARS) Functional Assessment Score
Time frame: 0, 4, 8 weeks
Change in Outcome Expectancies for Exercise and Technology Use
Time frame: 0, 4, 8 weeks
Change in System Usability Scale (SUS) Score
Time frame: 4, 8 weeks
Change in Learnability Score of the BandPass System
Time frame: 4, 8 weeks
Change in Efficiency and Technology Acceptance Questionnaire Scores
Time frame: 4, 8 weeks
Change in User Experience Questionnaire (UEQ) Scores
Time frame: 4, 8 weeks
Telehealth Usability Survey
Time frame: 4, 8 weeks
Change in Usefulness, Ease of Use, Ease of Learning, and Satisfaction Questionnaire Scores
Time frame: 4, 8 weeks
Willingness to Pay for the BandPass System
Time frame: 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
- Individual participant dataSharing planned: No. Study data is proprietary.
Related trials for Sarcopenia
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruitingPhase 2
MF-300 for Treatment of Age-Related Sarcopenia
Sarcopenia in Elderly
Not yet recruitingObservational study
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism
Hypothyroidism, Psychometrics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Eric Ryan, PhD principal investigator
University of North Carolina, Chapel Hill
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BandPass System in people with Sarcopenia and Frailty, run by SynchroHealth LLC at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Viviana Nieto, BS (919-962-3412, Viviana_Nieto@med.unc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise Session Adherence to the Bandpass System (time frame: 0, 4, 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.